Souhaitez-vous accéder aux communiqués récents ?

SHENZHEN, CHINA, March 13, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat...

SHENZHEN, CHINA, March 13, 2026 (GLOBE NEWSWIRE) -- On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings...

Rad Source launches Configurable Filters for the RS 2000·Q2, giving researchers greater control and flexibility in tailoring X‑ray beam profiles.

Toronto, Canada, March 10, 2026 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the Canadian launch of two new innovative...

McHenry, Illinois, March 10, 2026 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 breast pump brand used in hospitals1, today announced the launch of two new...

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus...

ZimCal shows why the recent debt maturity and paydown is just more evidence of serious underlying issues with MFIN - a result of poor leadership

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for larger batches and greater...

SHENZHEN, CHINA, March 05, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small...

SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal...